Shares of Arch Therapeutics, Inc. (OTCMKTS:ARTH – Get Free Report) crossed below its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $0.12 and traded as low as $0.00. Arch Therapeutics shares last traded at $0.00, with a volume of 1 shares trading hands.
Arch Therapeutics Stock Down 100.0%
The firm’s 50 day moving average price is $0.12.
Arch Therapeutics Company Profile
Arch Therapeutics, Inc, together with its subsidiaries, operates as a biotechnology company in the United States. It develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease.
See Also
- Five stocks we like better than Arch Therapeutics
- Investing in Construction Stocks
- Is Qualcomm Tesla’s Next Rival in Autonomous Driving?
- Insider Buying Explained: What Investors Need to Know
- 3 Under-the-Radar Biotechs Under $5 That Could Soar 200%
- Are Penny Stocks a Good Fit for Your Portfolio?
- The Quiet Before the Catalyst: Vertical Aerospace’s Next Move
Receive News & Ratings for Arch Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arch Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
